Generated by AI
iShares Genomics Immunology and Healthcare ETF is an equity exchange-traded fund that aims to track a global index of companies linked to genomics, immunology, and bioengineering. It provides diversified exposure across the healthcare innovation ecosystem, including biotechnology, biopharmaceuticals, and healthcare equipment and services. The fund is designed for investors seeking access to businesses involved in gene-based research, immune-system therapies, and related medical technologies, with holdings selected from global markets and weighted through an index-based approach. By focusing on life sciences and healthcare innovation, iShares Genomics Immunology and Healthcare ETF plays a niche role in the market as a thematic fund centered on scientific advancement and specialized healthcare development.
The latest articles about IDNA.
Summary of Oct 15's posts. Generated by AI.
No summary yet.
No summary yet.
No summary yet.
No summary yet.
Investors talking about IDNA also mention these. Each card shows that asset’s own numbers for the past 24 hours.